BSX
Boston Scientific Corp
Boston Scientific Corp historical holders
total: 8
Appaloosa Management Boston Scientific Corp transactions over time
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 4
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 3 quarters
- Latest activity:
- 2020 Q4
David Tepper has been an institutional investor in Boston Scientific Corp (BSX) since 2016 Q4. According to 2026 Q1 report, David Tepper doesn't hold any shares. The fund/company first acquired BSX in 2016 Q4, initially purchasing 550,000 shares. David Tepper later completely sold out the position and reinvested in BSX again in 2020 Q1. Since the initial investment, Appaloosa Management has made 12 more transactions in this position.
When did David Tepper exit their BSX position?
David Tepper no longer holds Boston Scientific Corp (BSX). They sold off their entire position in 2020 Q4, closing out an investment that began in 2016 Q4.
When did David Tepper first invest in BSX?
David Tepper first invested in Boston Scientific Corp (BSX) in 2016 Q4 at the reported quarter-end price of $21.63 per share, acquiring 550,000 shares in their initial purchase.
What is David Tepper's average cost basis for BSX?
Based on historical transaction data, David Tepper's estimated cost basis for Boston Scientific Corp (BSX) is approximately $34.81 per share. This represents their average reported price* across all buy transactions.
Has David Tepper reinvested in BSX after selling?
Yes, David Tepper has shown renewed interest in Boston Scientific Corp (BSX). After completely selling their position, they reinitiated an investment in 2020 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $34.81
- Weighted AVG sell price:
- $38.21
BSX transactions history by Appaloosa Management
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2020 Q4
|
0.00%
|
$38.21
|
-100% (-787,500)
|
|||
|
2020 Q3
|
0.53%
|
$38.21
|
-17.11% (-162,500)
|
|||
|
2020 Q2
|
0.58%
|
$35.11
|
+726.09% (+835,000)
|
|||
|
2020 Q1
|
0.11%
|
$32.63
|
new
|
|||
|
2018 Q4
|
0.00%
|
$38.50
|
-100% (-853,875)
|
|||
|
2018 Q3
|
0.58%
|
$38.50
|
-66.23% (-1,674,263)
|
|||
|
2018 Q2
|
0.95%
|
$32.70
|
-35.35% (-1,382,600)
|
|||
|
2018 Q1
|
1.10%
|
$27.32
|
-18.23% (-871,945)
|
|||
|
2017 Q4
|
1.13%
|
$24.79
|
+27.44% (+1,029,817)
|
|||
|
2017 Q3
|
1.58%
|
$29.17
|
+65.70% (+1,487,966)
|
|||
|
2017 Q2
|
0.93%
|
$27.72
|
-32.19% (-1,075,100)
|
|||
|
2017 Q1
|
1.45%
|
$24.87
|
+507.27% (+2,790,000)
|
|||
|
2016 Q4
|
0.22%
|
$21.63
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.